Your session is about to expire
← Back to Search
Tirzepatide for Pediatric Obesity
Study Summary
This trial will analyze safety and tolerability of tirzepatide in kids w/ obesity. Blood tests will investigate how body processes drug. Study lasts 13 wks (not inc. screen).
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowTimeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Side effects data
From 2022 Phase 3 trial • 210 Patients • NCT05024032Trial Design
Find a Location
Who is running the clinical trial?
Media Library
- My obesity is caused by a hormonal disorder or a specific genetic condition.I don't have major health issues that could affect drug processing or pose risks with the study drug.I have been diagnosed with type 1 or type 2 diabetes.My BMI is in the top 5% for my age and sex.I am a female and have not started puberty.I have had pancreatitis or other stomach/intestine problems.I have had significant weight loss surgery or related treatments in the last 6 months.
- Group 1: Tirzepatide
- Group 2: Placebo
- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
To whom does this clinical trial offer access?
"This medical trial seeks to enrol 30 individuals aged between 6 and 11 who are confronting obesity. Specifically, the study requires both male and female participants with a body weight of at least 50 kilogram (kg) for cohort 1 or below that limit for cohorts 2 & 3; plus their BMI must exceed the 95th percentile according to age and gender."
Is there an open enrollment window for this research endeavor?
"According to clinicaltrials.gov, this particular trial is unfortunately no longer accepting applications as the last update was on January 17th 2023. However, there are other 922 studies presently recruiting candidates."
Does this trial accept participants aged 85 or over?
"This clinical trial is only open to individuals aged 6-11. However, there are 194 studies for minors and 578 trials for seniors within the same field of medicine."
Are there any potential risks associated with Tirzepatide use?
"Due to limited clinical evidence, our team at Power gauged the safety of Tirzepatide a score of 1. This medication is still in its first phase trial."
Who else is applying?
What state do they live in?
What site did they apply to?
What portion of applicants met pre-screening criteria?
How many prior treatments have patients received?
Why did patients apply to this trial?
What questions have other patients asked about this trial?
Share this study with friends
Copy Link
Messenger